![](/img/cover-not-exists.png)
Is there still a future for neurokinin 3 receptor antagonists as potential drugs for the treatment of psychiatric diseases?
Guy Griebel, Sandra BeeskéVolume:
133
Year:
2012
Language:
english
Pages:
8
DOI:
10.1016/j.pharmthera.2011.09.007
File:
PDF, 494 KB
english, 2012